💰$120k-$140k
📍United States
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company focused on establishing gene therapy as a new standard of care for prevalent ocular diseases. Utilizing its proprietary intravitreal (IVT) platform, Adverum develops durable, single-administration therapies to eliminate frequent ocular injections. The company is advancing ixoberogene soroparvovec (Ixo-vec) for neovascular age-related macular degeneration. Adverum aims to transform care, preserve vision, and make a global impact.
Note: Jobs without salary info will not be shown in the results
Loading data, please wait.
Loading data, please wait.